Decatur Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-84,400
| Closed | -$7.19M | – | 58 |
|
|
2018
Q4 | $7.19M | Buy |
84,400
+15,800
| +23% | +$1.35M | 1.62% | 26 |
|
|
2018
Q3 | $6.65M | Sell |
68,600
-17,050
| -20% | -$1.65M | 1.53% | 33 |
|
|
2018
Q2 | $8.07M | Buy |
+85,650
| New | +$8.07M | 1.6% | 33 |
|
|
2017
Q2 | – | Sell |
-77,345
| Closed | -$6.79M | – | 51 |
|
|
2017
Q1 | $6.79M | Sell |
77,345
-19,380
| -20% | -$1.7M | 1.32% | 43 |
|
|
2016
Q4 | $8.01M | Sell |
96,725
-15,875
| -14% | -$1.32M | 1.15% | 43 |
|
|
2016
Q3 | $10.4M | Buy |
+112,600
| New | +$10.4M | 1.31% | 44 |
|